Clinical Trial Update: ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT [NA]

View source ↗

Summary

A clinical trial comparing ACE inhibitors/ARBs alone versus ACE inhibitors/ARBs plus steroids for primary IgA nephropathy; the study status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• ACE inhibitors
• Angiotensin II receptor blockers (ARB)
• Corticosteroids (corticosteroids)

Snippet

Sponsor: Peking University | Conditions: Glomerulonephritis, IGA | NA | Status: UNKNOWN